MRS studies of cancer

Abstract

Cancer was an obvious disease to study by magnetic resonance spectroscopy (MRS); it produces large lesions that give clearly abnormal spectra, all treatment methods leave much to be desired, and radiotherapy, in particular, is limited by tissue hypoxia, a process that can be investigated by MRS.³¹P MRS has shown that tumor cells are not acidic, as had been thought; instead, the pH gradient across the tumor cell membrane is the reverse of that in a normal cell. This change in hydrogen-ion gradient is accompanied by changes in gradients of many other ions.

Tumor oxygenation can be monitored in animal tumor models using the techniques employed for functional magnetic resonance imaging (MRI) of the brain. Large changes in signal are observed when drugs that reduce tumor blood flow are administered.

¹H NMR spectra of acid extracts of tumor or normal tissue biopsies contain sufficient information to permit classification (and thus, perhaps, diagnosis) if computer-based pattern recognition techniques are employed. Surprisingly, the same technique gives quite good classification of³¹P spectra takenin vivo.

Can MRS beappliedin cancer therapy? Studies on tumor ion balance will help in the design of anticancer drugs and other therapies. Tumor blood flow studies using MRI could be applied to individual patients to predict the usefulness of radiotherapy and to assist in radiotherapy planning. Pattern recognition methods could automate the screening of biopsies and could also assist in interpretation of human spectra takenin vivo.